Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV‐negative people at risk of active TB
Background Preventing active tuberculosis (TB) from developing in people with latent
tuberculosis infection (LTBI) is important for global TB control. Isoniazid (INH) for six to nine …
tuberculosis infection (LTBI) is important for global TB control. Isoniazid (INH) for six to nine …
Self-administered versus directly observed once-weekly isoniazid and rifapentine treatment of latent tuberculosis infection: a randomized trial
Background: Expanding latent tuberculosis treatment is important to decrease active
disease globally. Once-weekly isoniazid and rifapentine for 12 doses is effective but limited …
disease globally. Once-weekly isoniazid and rifapentine for 12 doses is effective but limited …
Treatment of latent tuberculosis infection
A Vernon - Seminars in respiratory and critical care medicine, 2013 - thieme-connect.com
Latent tuberculosis infection (LTBI) refers to a circumstance in which viable Mycobacterium
tuberculosis (MTB) bacilli are present in an individual but symptoms and signs of active …
tuberculosis (MTB) bacilli are present in an individual but symptoms and signs of active …
Health system costs of treating latent tuberculosis infection with four months of rifampin versus nine months of isoniazid in different settings
ML Bastos, JR Campbell, O Oxlade… - Annals of internal …, 2020 - acpjournals.org
Background: Four months of rifampin treatment for latent tuberculosis infection is safer, has
superior treatment completion rates, and is as effective as 9 months of isoniazid. However …
superior treatment completion rates, and is as effective as 9 months of isoniazid. However …
Twelve-week rifapentine plus isoniazid versus 9-month isoniazid for the treatment of latent tuberculosis in renal transplant candidates
J Simkins, LM Abbo, JF Camargo, R Rosa… - Transplantation, 2017 - journals.lww.com
Background Renal transplant candidates (RTC) with latent tuberculosis infection (LTBI) are
at significant risk for tuberculosis reactivation. Twelve-week rifapentine (RPT)/isoniazid (INH) …
at significant risk for tuberculosis reactivation. Twelve-week rifapentine (RPT)/isoniazid (INH) …
The global expansion of LTBI screening and treatment programs: exploring gaps in the supporting economic evidence
NT Kota, S Shrestha, A Kashkary, P Samina… - Pathogens, 2023 - mdpi.com
The global burden of latent TB infection (LTBI) and the progression of LTBI to active TB
disease are important drivers of ongoing TB incidence. Addressing LTBI through screening …
disease are important drivers of ongoing TB incidence. Addressing LTBI through screening …
House calls by community health workers and public health nurses to improve adherence to isoniazid monotherapy for latent tuberculosis infection: a retrospective …
AH Chang, A Polesky, G Bhatia - BMC public health, 2013 - Springer
Background Patient adherence to isoniazid (INH) monotherapy for latent tuberculosis
infection (LTBI) has been suboptimal despite its proven efficacy. Various strategies have …
infection (LTBI) has been suboptimal despite its proven efficacy. Various strategies have …
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
WA Lai, K Brethour, O D'Silva, RE Chaisson… - BMC public health, 2022 - Springer
Background We conducted a systematic review examining the cost effectiveness of a 3-
month course of isoniazid and rifapentine, known as 3HP, given by directly observed …
month course of isoniazid and rifapentine, known as 3HP, given by directly observed …
[PDF][PDF] К дискуссии о латентной туберкулезной инфекции
ПН Филимонов - Туберкулез и болезни легких, 2014 - tibl-journal.com
Латентную туберкулезную инфекцию (ЛТИ) изучают около 60 лет. Рост интереса к ней
(количество и качество публикаций в базе Medline) пришелся на 2000 г., после …
(количество и качество публикаций в базе Medline) пришелся на 2000 г., после …
An update on the use of rifapentine for tuberculosis therapy
JGY Chan, X Bai, D Traini - Expert opinion on drug delivery, 2014 - Taylor & Francis
Introduction: Tuberculosis (TB) remains rampant throughout the world, in large part due to
the lengthy treatment times of current therapeutic options. Rifapentine, a rifamycin antibiotic …
the lengthy treatment times of current therapeutic options. Rifapentine, a rifamycin antibiotic …